PATENT CLAIM ANALYSIS

Application Number: 16011723
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "411000"]

Abstract:
The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.

Claim (Index 3):
The method according to  claim 1 , wherein said antagonist has formula (I) or pharmaceutically acceptable salts thereof, wherein n is 0 or 1; m is 1, 2 or 3; R 1  is H, C 1 -C 3  alkyl, halogenated C 1 -C 3  alkyl or cyclopropyl; R 2  is 4-chlorophenyl or 2,4,6-trichlorophenyl.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.57692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15498202', '13989744', '15234754', '14192911', '14114733']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7364523110717595
- 35 USC 102 Novelty (BERT): 0.5407330284445371
- Combined Prediction Score: 0.7168803828090372
- Mean Citation Score: 261.078156
- Max Citation Score: 355.7615
- Similarity Product: 228.89464253473287

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test